 |
July-September 2008 Volume 4 | Issue 3
Page Nos. 105-146
Online since Saturday, September 27, 2008
Accessed 91,500 times.
PDF access policy Journal allows immediate open access to content in HTML + PDF
EPub access policy Full text in EPub is free except for the current issue. Access to the latest issue is reserved only for the paid subscribers.
|
| |
|
Show all abstracts Show selected abstracts Add to my list |
|
EDITORIAL |
|
|
|
HPV vaccine for primary prevention of cervical cancer in developing countries: The missing links |
p. 105 |
Rajiv Sarin DOI:10.4103/0973-1482.43138 PMID:18923200 |
[HTML Full text] [PDF] [Citations (6) ] [PubMed] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
ORIGINAL ARTICLES |
 |
|
|
|
Paradox of wellness and nonadherence among Nigerian women on breast cancer chemotherapy |
p. 107 |
Adewale Oluseye Adisa, Oladejo Olukayode Lawal, Abdul Rasheed Kayode Adesunkanmi DOI:10.4103/0973-1482.42640 PMID:18923201Context: Intentional nonadherence among cancer patients is rare and may occur only when the benefits of treatment are not obvious to the patient.
Aims: To highlight a group of women on chemotherapy for breast cancer who defaulted from their medications because they were improving.
Settings and Design: A study was carried out of the reasons for nonadherence to medications among women receiving chemotherapy for breast cancer at a Nigerian teaching hospital between January 1993 and December 2002.
Materials and Methods: A retrospective review of patients' records was done.
Results: Of the 188 women who received chemotherapy during the study period, 152 (80.9%) defaulted from treatment at one point or another. The reasons for nonadherence were available in 101 patients. Among these, 18 (18.0%) reported nonadherence because they felt better after commencing chemotherapy. They were aged 31-50 years (Mean = 35.6 (SD3.2)). Six (33.3%) of them presented in AJCC Stage I, and 10 (55.6%) in stage II. Age and disease stage at presentation were found to have significant influence on their reason for nonadherence. Of the nine women on neo-adjuvant chemotherapy, six (66.7%) had complete response but defaulted and five (55.6%) re-presented within a year with metastatic disease. Three of the patients receiving systemic post-surgery chemotherapy presented within a year with local recurrence. Most of the other patients were subsequently lost to follow-up.
Conclusions: Nonadherence due to wellness among breast cancer patients is associated with poor outcome. We propose a detailed prospective study to establish factors that may influence such behavior. |
[ABSTRACT] [HTML Full text] [PDF] [Citations (11) ] [PubMed] [Sword Plugin for Repository]Beta |
|
|
|
|
|
 |
Amelioration of cisplatin induced nephrotoxicity in Swiss albino mice by Rubia cordifolia extract |
p. 111 |
Jisha Joy, Cherupally Krishnan Krishnan Nair DOI:10.4103/0973-1482.43139 PMID:18923202Background: Cisplatin is one of the most effective chemotherapeutics against a wide range of cancers including head, neck, ovarian and lung cancers. But its usefulness is limited by its toxicity to normal tissues, including cells of the kidney proximal tubule. The purpose of the present study is to investigate whether the hydro-alcoholic extract of Rubia cordifolia could decrease the intensity of toxicity in Swiss albino mice.
Materials and Methods: Cisplatin at a dose of 12 mg/kg body wt was administered intraperitoneally to Swiss albino mice. Another set of animals was given hydro-alcoholic extract of Rubia cordifolia at different doses along with cisplatin treatment. The antioxidant levels, serum creatinine, serum urea etc. were analyzed.
Results: The extract could significantly decrease the cisplatin induced nephrotoxicity as inferred from the tissue antioxidant status in the drug administered animals. Remarkable change was observed in serum creatinine and urea levels. Lipid peroxidation in the kidney and liver tissues was also considerably reduced in Rubia cordifolia extract treated animals.
Conclusion: Hydro-alcoholic extracts of Rubia cordifolia are effective in reducing the renal damage caused by the cancer chemotherapeutic drug cisplatin. Since Rubia cordifolia has been in use as an important ingredient in the traditional Ayurvedic system of medicine, it could be safe and beneficial to use this herbal extract as an adjuvant to ameliorate renal damage in patients undergoing cancer chemotherapy with cisplatin. |
[ABSTRACT] [HTML Full text] [PDF] [Citations (38) ] [PubMed] [Sword Plugin for Repository]Beta |
|
|
|
|
|
 |
Quality of life outcome measures following partial glossectomy: Assessment using the UW-QOL scale |
p. 116 |
R Kazi, C Johnson, V Prasad, J De Cordova, R Venkitaraman, CM Nutting, P Clarke, P Rhys Evans, KJ Harrington DOI:10.4103/0973-1482.42641 PMID:18923203Background: The consequences of a diagnosis of head and neck cancer and the impact of treatment have a clear and direct influence on well-being and associated quality of life (QOL) in these patients.
Aims: To determine the QOL in head and neck cancer patients following a partial glossectomy operation.
Design and Setting: Cross-sectional cohort study; Head and Neck Oncology Unit, tertiary referral center.
Materials and Methods: 38 patients with partial glossectomy were assessed with the University of Washington head and neck quality of life (UW-QOL) scale, version 4.
Statistical Analysis: Statistical analysis was performed using the Statistical Package for Social Sciences 10.0 (SPSS Inc, Chicago version III). Information from the scale was correlated using the Mann Whitney test. A P value less than/equal to 0.05 was considered as significant.
Results: The mean (sd) composite score of the QOL in our series was 73.6 (16.1). The majority (71.8%) quoted their QOL as good or very good. Swallowing (n = 16, 47.1%), speech (n = 15, 44.1%) and saliva (n = 15, 44.1%) were most commonly cited issues over the last 7 days. On the other hand, the groups with reconstruction, neck dissection, complications and radiotherapy demonstrated a significant reduction of quality of life scores (Mann Whitney test, P < 0.05).
Conclusion: The composite score and overall QOL as assessed using the UW-QOL scale (version 4) were modestly high in our series of partial glossectomy patients. Swallowing, speech, and saliva are regarded as the most important issues. Stage of the disease, neck dissection, reconstruction, complications, radiotherapy and time since operation were seen to significantly affect domain scores. |
[ABSTRACT] [HTML Full text] [PDF] [Citations (21) ] [PubMed] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
Comparative evaluation between re-irradiation and demand endoscopic dilatation vs endoscopic dilatation alone in patients with recurrent/reactivated residual in-field esophageal malignancies |
p. 121 |
Mohmad Ashraf Teli, G Nabi Mushood, S Ali Zargar, Wajahat H Andrabi DOI:10.4103/0973-1482.43140 PMID:18923204Background: Esophageal cancer has emerged as a major health challenge in many regions of the world, including the valley of Kashmir, which is situated adjacent to the esophageal cancer belt on its Southern side. Radiotherapy is one of the main modalities of treatment. However, residual/recurrent disease is common and salvage options for these patients are limited. Scarce literature is available regarding the use of re-irradiation in this setting though re-irradiation has been successfully used in recurrent tumors at various other anatomical sites.
Aim: In the present study, external beam re-irradiation with demand dilatation vs per-oral endoscopic dilatation alone were compared with regard to the impact of these modalities on symptom control, survival, and quality of life of the patients. Treatment-related sequelae were also compared.
Setting and Design: Prospective and randomized.
Materials and Methods: The study included 34 cases who were palliated with re-irradiation and 35 cases who refused to enter the experimental protocol and, therefore, received per-oral demand dilatation alone, with the disease being allowed to follow its natural course. Both groups were statistically cross-matched with regard to their demographic and clinical parameters.
Statistical Method Used: Mann-Whitney U-test, Chi-square test, Student's t-test, and Kaplan-Meier test for survival analysis.
Results: The results favor the use of re-irradiation as it significantly improves dysphagia-free survival and quality of life. The treatment-related complications/morbidity of this protocol was acceptable.
Conclusion: A trial of re-irradiation with external beam is justified in selected patients. |
[ABSTRACT] [HTML Full text] [PDF] [Citations (5) ] [PubMed] [Sword Plugin for Repository]Beta |
|
|
|
|
|
 |
Normal tissue complication probability of fibrosis in radiotherapy of breast cancer: Accelerated partial breast irradiation vs conventional external-beam radiotherapy |
p. 126 |
KS Jothy Basu, Amit Bahl, V Subramani, DN Sharma, GK Rath, PK Julka DOI:10.4103/0973-1482.43143 PMID:18923205Aims: Radiotherapy forms an integral part of breast-conserving treatment in early-stage breast cancer. Subcutaneous fibrosis of the treated breast is an important late effect in whole-breast irradiation. The aim of this study was to compare the normal tissue complication probability (NTCP) for radiation-induced fibrosis in treated breast using accelerated partial-breast irradiation (APBI) vs conventional treatment.
Materials and Methods: Ten postoperative early-stage breast cancer patients (T1N0M0) were included in this dosimetric analysis. APBI treatment was planned using conformal radiotherapy technique and conventional treatment plans included two tangential portals. All the APBI treatment plans were made with five non-coplanar beams with 6 MV photons. The prescription dose was 38 Gy in 10 fractions for the APBI treatments and 50 Gy in 25 fractions, followed by a boost dose of 16 Gy in 8 fractions, for the conventional treatments. We used Lyman's relative-seriality model and the breast fibrosis NTCP model fitting parameters for the study.
Results: The equivalent uniform dose (EUD) was 30.09 Gy and 50.79 Gy in APBI and conventional treatment, respectively. The mean NTCP values for ipsilateral breast fibrosis in APBI and conventional treatment were 0.51 and 25.66%, respectively. Using the paired t-test, a statistically significant difference was seen in the breast fibrosis NTCP values for APBI vs conventional treatment (P <0.001).
Conclusions: APBI reduces the ipsilateral breast fibrosis compared to conventional whole-breast treatment in early-stage breast cancer. |
[ABSTRACT] [HTML Full text] [PDF] [Citations (15) ] [PubMed] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
BRIEF COMMUNICATION |
 |
|
|
 |
Sarcomatoid carcinoma of the maxillary sinus: A rare head and neck tumor |
p. 131 |
Milind Kumar, Shikha Goyal, Amit Bahl, Prasenjit Das, DN Sharma, Ruma Ray, GK Rath DOI:10.4103/0973-1482.43146 PMID:18923206Sarcomatoid carcinomas are rare tumors. These tumors have been reported at other sites, but head and neck origin is extremely uncommon. We report here a rare case of sarcomatoid carcinoma involving the maxilla. Only four such cases with maxillary origin have been discussed in English literature earlier. As compared to squamous cell carcinoma of maxilla, this variant is associated with poor prognosis and advanced disease at presentation, as was also seen in our case. There are no standard recommendations for management owing to the rarity of this histology. Surgery and radiotherapy form the mainstays of treatment. Exploration of the role of chemotherapy and novel targeted therapy agents is warranted in order to improve treatment results. |
[ABSTRACT] [HTML Full text] [PDF] [Citations (4) ] [PubMed] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
CASE REPORTS |
 |
|
|
 |
Pulmonary sarcoidosis simulating metastatic breast cancer |
p. 134 |
Dimitrios M Dragoumis, Aris P Tsiftsoglou, Anthoula S Assimaki DOI:10.4103/0973-1482.43148 PMID:18923207The clinical appearance and imaging findings of sarcoidosis and breast carcinoma may sometimes mimic one another, making the differential diagnosis between these two diseases difficult in some cases.
A 69-year-old woman displayed an irregular shaped lesion in her left breast. Preoperative localization modalities detected a breast mass with malignant characters. The patient also was found to have pulmonary findings for metastatic disease on chest computed tomography. These features were proven upon biopsy to be consistent with sarcoidosis. The patient underwent breast surgery, adjuvant chemoradiotherapy and hormonal therapy, while corticosteroids were administered for pulmonary sarcoidosis. The patient is well 12 months later, without recurrence.
An unfortunate consequence of the presence of both entities in the same patient is the risk of misguided differential diagnosis and incorrect therapeutic strategy. This patient shows the importance of confirming a clinical diagnosis of sarcoidosis with appropriate biopsies and histological examination, prior to initiation of breast cancer therapy. |
[ABSTRACT] [HTML Full text] [PDF] [Citations (6) ] [PubMed] [Sword Plugin for Repository]Beta |
|
|
|
|
|
 |
Granulocytic sarcoma masquerading as Ewing's sarcoma: A diagnostic dilemma |
p. 137 |
Kunhi Parambath Haresh, Nikhil Joshi, Chaitali Gupta, Ramachandran Prabhakar, Daya Nand Sharma, Pramod Kumar Julka, Goura Kishor Rath DOI:10.4103/0973-1482.43150 PMID:18923208An eleven-year-old boy presented with a swelling in his left elbow. Radiologically the features were that of an Ewing's sarcoma involving the ulna. Histopathology showed small round cell tumor strongly positive for Monoclonal Imperial Cancer research fund 2 (MIC2) antigen. Similar cells in the bone marrow were involved with MIC2 positivity. The patient developed skin lesions, which on biopsy were found to be chloromas. The initial biopsies were reevaluated with special stains revealing granulocytic sarcomas in acute myeloid leukemia masquerading as Ewing's due to its MIC2 positivity. The possibility of myeloid neoplasms should be considered routinely with known MIC2 positive round cell tumors.
|
[ABSTRACT] [HTML Full text] [PDF] [Citations (16) ] [PubMed] [Sword Plugin for Repository]Beta |
|
|
|
|
|
 |
Suprasellar ganglioglioma with unusual diffuse involvement of the entire optico-chiasmal hypothalamic pathway |
p. 140 |
Rakesh Jalali, Chandrashekar E Deopujari, Ritu Bhutani, U Suhas, Preetha Rajasekharan, Shubdha V Kane, Tejpal Gupta DOI:10.4103/0973-1482.43151 PMID:18923209Gangliogliomas (GG) are mixed glioneuronal tumors of the central nervous system (CNS), occurring mostly in the pediatric population, with common sites being temporal lobes and less commonly in the frontal and parietal lobes. We report a case of a 7-year-old child who presented with bilateral visual defects for 6 months. Magnetic resonance imaging (MRI) of the brain revealed an intensely enhancing mass lesion with calcification in the sellar and suprasellar region involving the optic chiasm and the left optic nerve. The mass showed almost bilaterally symmetrical diffuse spread along the optic tracts posteriorly and hypothalamus, temporal lobes, thalami and the basal ganglia. The lesion was radiologically indistinguishable from chiasmatic astrocytoma or a germ cell tumor but histopathological features were of a ganglioglioma. While a few optic apparatus gangliogliomas have been reported in the literature, such widespread diffuse involvement of the entire optico-chiasmal hypothalamic pathway is unusual. |
[ABSTRACT] [HTML Full text] [PDF] [Citations (11) ] [PubMed] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
LETTERS TO EDITOR |
 |
|
|
|
Radiofrequency ablation should not be considered as an alternative to surgical resection |
p. 144 |
Rajeev Sharma DOI:10.4103/0973-1482.43152 PMID:18923210 |
[HTML Full text] [PDF] [Citations (2) ] [PubMed] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
Radiofrequency ablation in liver metastasis: Authors' reply |
p. 145 |
GK Rath, PK Julka, S Thulkar, DN Sharma, Amit Bahl, S Bhatnagar DOI:10.4103/0973-1482.43153 |
[HTML Full text] [PDF] [Sword Plugin for Repository]Beta |
|
|
|
|
|
|
Dilemmas of Plenty |
p. 146 |
Amit Agrawal DOI:10.4103/0973-1482.43154 PMID:18923211 |
[HTML Full text] [PDF] [PubMed] [Sword Plugin for Repository]Beta |
|
|
|
|
|